, Global Health Sector Strategy on Viral Hepatitis, 2016.

N. A. Terrault, A. Lok, and B. J. Mcmahon, Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance, Hepatology, vol.67, pp.1560-1599, 2018.

, European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection, J Hepatol, vol.67, pp.370-398, 2017.

S. K. Sarin, M. Kumar, and G. K. Lau, Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update, Hepatol Int, vol.10, pp.1-98, 2016.

, Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection, 2015.

D. Razavi-shearer, I. Gamkrelidze, and M. H. Nguyen, Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study, Lancet Gastroenterol Hepatol, vol.3, pp.383-403, 2018.

S. F. Andriamandimby, M. M. Olive, and Y. Shimakawa, Prevalence of chronic hepatitis B virus infection and infrastructure for its diagnosis in Madagascar: Implication for the WHO's elimination strategy, BMC Public Health, vol.17, p.636, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-01653384

, Guidelines on hepatitis B and C testing, 2017.

T. Kimura, A. Rokuhara, and Y. Sakamoto, Sensitive Enzyme Immunoassay for Hepatitis B Virus Core-Related Antigens and Their Correlation to Virus Load Sensitive Enzyme Immunoassay for Hepatitis B Virus Core-Related Antigens and Their Correlation to Virus Load, J Clin Microbiol, vol.40, pp.439-445, 2002.

D. Wong, Y. Tanaka, C. L. Lai, M. Mizokami, J. Fung et al., Hepatitis B virus corerelated antigens as markers for monitoring chronic hepatitis B infection, J Clin Microbiol, vol.45, pp.3942-3947, 2007.

F. Suzuki, H. Miyakoshi, M. Kobayashi, and H. Kumada, Correlation between serum hepatitis B virus core-related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients, J Med Virol, vol.81, pp.27-33, 2009.

B. Maasoumy, S. B. Wiegand, and J. Jaroszewicz, Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D, Clin Microbiol Infect, vol.21, pp.606-607, 2015.

M. Riveiro-barciela, M. Bes, and F. Rodríguez-frías, Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotype, Clin Microbiol Infect, vol.23, pp.860-867, 2017.

D. Wong, W. K. Seto, and K. S. Cheung, Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA, Liver Int, vol.37, pp.995-1001, 2017.

B. Testoni, F. Lebossé, and C. Scholtes, Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients, J Hepatol, vol.70, pp.615-625, 2019.

L. Duchesne, R. Njouom, and F. Lissock, HCV Ag quantification as a one-step procedure in diagnosing chronic hepatitis C infection in Cameroon: The ANRS 12336 study, J Int AIDS Soc, vol.20, pp.1-8, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01536669

Z. Mohamed, J. Mbwambo, and Y. Shimakawa, Clinical utility of HCV core antigen detection and quantification using serum samples and dried blood spots in people who inject drugs in, J Int AIDS Soc, vol.20, p.21856, 2017.

J. M. Freiman, T. M. Tran, and S. G. Schumacher, Hepatitis C core antigen testing for diagnosis of hepatitis C virus infection: A systematic review and meta-analysis, Ann Intern Med, vol.165, pp.345-355, 2016.

M. Lemoine, Y. Shimakawa, and R. Njie, Acceptability and feasibility of a screen-andtreat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study, Lancet Glob Heal, vol.4, pp.559-567, 2016.

Y. Shimakawa, M. Lemoine, and H. F. Njai, Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia, Gut, vol.65, pp.2007-2016, 2016.

Y. Shimakawa, M. Lemoine, and C. Bottomley, Birth order and risk of hepatocellular carcinoma in chronic carriers of hepatitis B virus: a case-control study in The Gambia, Liver Int, vol.35, pp.2318-2326, 2015.

M. Lemoine, Y. Shimakawa, and R. Njie, Food intake increases liver stiffness measurements and hampers reliable values in patients with chronic hepatitis B and healthy controls: the PROLIFICA experience in The Gambia, Aliment Pharmacol Ther, vol.39, pp.188-96, 2014.

S. Ghosh, A. Sow, and C. Guillot, Implementation of an in-house quantitative real-time polymerase chain reaction method for Hepatitis B virus quantification in West African countries, J Viral Hepat, vol.23, pp.897-904, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01792611

M. Lemoine, Y. Shimakawa, and S. Nayagam, The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa, Gut, vol.65, pp.1369-76, 2016.

Y. Shimakawa, E. Bah, C. P. Wild, and A. J. Hall, Evaluation of data quality at the Gambia National Cancer Registry, Int J Cancer, vol.132, pp.658-65, 2013.

Y. Shimakawa, R. Njie, and G. Ndow, Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa, J Hepatol, vol.69, pp.776-784, 2018.
URL : https://hal.archives-ouvertes.fr/pasteur-01896895

P. M. Bossuyt, J. B. Reitsma, and D. E. Bruns, RESEARCH METHODS & REPORTING STARD 2015 : an updated list of essential items for, Radiology, vol.277, pp.826-832, 2015.

L. Y. Mak, D. Wong, K. S. Cheung, W. K. Seto, C. L. Lai et al., Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection, Aliment Pharmacol Ther, vol.47, pp.43-54, 2018.

C. Lai, D. Wong, and P. Ip, Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B, J Hepatol, vol.66, pp.275-281, 2017.

M. Cornberg, V. Wong, S. Locarnini, M. Brunetto, H. Janssen et al., The role of quantitative hepatitis B surface antigen revisited, J Hepatol, vol.66, pp.398-411, 2017.

E. Q. Chen, S. Feng, and M. L. Wang, Serum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis B, Sci Rep, vol.7, pp.1-8, 2017.

N. Chuaypen, N. Posuwan, and S. Chittmittraprap, Predictive role of serum HBsAg and HBcrAg kinetics in patients with HBeAg-negative chronic hepatitis B receiving pegylated interferon-based therapy, Clin Microbiol Infect, vol.24, pp.306-313, 2018.

M. Honda, T. Shirasaki, and T. Terashima, Hepatitis B virus (HBV) core-related antigen during nucleos(t)ide analog therapy is related to intra-hepatic HBV replication and development of hepatocellular carcinoma, J Infect Dis, vol.213, pp.1096-1106, 2016.

W. K. Seto, Y. R. Lo, J. M. Pawlotsky, and M. F. Yuen, Chronic hepatitis B virus infection, Lancet, vol.392, pp.2313-2324, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01796201

T. Tada, T. Kumada, and H. Toyoda, HBcrAg is a predictor of hepatocellular carcinoma development: an analysis using time-dependent receiver operating characteristics, J Hepatol, vol.65, pp.48-56, 2016.

T. Tada, T. Kumada, H. Toyoda, N. Kobayashi, T. Akita et al., Hepatitis B virus corerelated antigen levels predict progression to liver cirrhosis in hepatitis B carriers, J Gastroenterol Hepatol, vol.33, pp.918-925, 2018.

Y. Shimakawa, A. Seck, S. Nayagam, C. Toure-kane, and M. Lemoine, Screening strategies to prevent mother-to-child transmission of hepatitis B in sub-Saharan Africa, Lancet Gastroenterol Hepatol, vol.3, pp.222-223, 2018.
URL : https://hal.archives-ouvertes.fr/pasteur-01740755

W. Wen, M. Chang, and L. Zhao, Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention, J Hepatol, vol.59, pp.24-30, 2013.

A. Seck, F. Ndiaye, and S. Maylin, Poor Sensitivity of Commercial Rapid Diagnostic Tests for Hepatitis B e Antigen in Senegal, West Africa, Am J Trop Med Hyg, vol.99, pp.428-434, 2018.

, Adapted from the American Guidelines (AASLD, 2018) Positive ?4.8 ?70 for men, ?50 for women Positive

, Negative ?3.6 ?70 for men, ?50 for women Negative ?3.6 ?7.9 ?9.5

, Age >30 years

, Adapted from the Asian Pacific Guidelines, 2015.